1.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: 60 and over Sponsor: Other Protocol IDs: UPCC 17409, NCT01113502
|
|
2.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Supportive care Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: CLL2S, 2010-023022-20, NCT01397149
|
|
3.
|
Phase: Phase II, Phase I Type: Supportive care, Treatment Status: Enrolling by invitation Age: 18 to 82 Sponsor: Other Protocol IDs: Pro00032798, NCT01491594
|
|
4.
|
Phase: Phase II Type: Supportive care, Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 497115/003, UCLA-0503037-01, GSK-SB-497115/003, NCT00102726
|
|
5.
|
Phase: Phase I Type: Supportive care, Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: TRC105499, NCT00358540
|
|
6.
|
Phase: Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 112509, NCT00903422
|
|
7.
|
Phase: No phase specified Type: Treatment Status: Temporarily closed Age: 18 to 70 Sponsor: Other Protocol IDs: 10-346, NCT01286675
|